08:32

VolitionRx First Quarter 2024 Financial Results and Business Update

03:11

How Nu.Q Discover can support drug developers

12:19

VolitionRx Limited Full Fiscal Year 2023 Financial Results and Business Update

00:53

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan

04:26

Highlights from WVC 2024

56:04

Sepsis webinar INCLUDING Q&A

34:12

Unravelling the web of NETs in sepsis...part II

05:00

Highlights from London Vet Show 2023

14:19

Third Quarter 2023 Financial Results & Business Update

50:05

Breakthrough Cancer Detection Webinar including Q&A

23:01

Webinar - Breakthrough Cancer Detection Method

10:52

Second Quarter 2023 Financial Results & Business Update

05:30

Volition Capital Markets Day Highlights May 2023

01:39:06

Volition's Capital Markets Day

41:38

Unravelling the web of NETs in sepsis - webinar

12:57

VolitionRx Limited Full Fiscal Year 2022 Financial Results and Business Update

04:13

WVC 2023: Highlights

03:50

Volition’s Nu.Q® Vet Cancer Test now available for pre-order, at the point of care, through Heska.

00:41

Volition's Nu.Q® Vet Cancer Test - now available for pre-order at the point of care via Heska.

02:25

Introducing the Nu.Q® Vet Cancer Test

17:36

Webinar: Commercializing the Nu.Q® Vet Cancer Test.

04:44

Highlights of the London Vet Show 2022

04:31

VMX 2023 Highlights

03:16

Volition expands availability of Nu.Q® Vet Cancer Test Through IDEXX Reference Laboratory Network

02:43

Volition Review of the Year 2022

11:31

Third Quarter 2022 Financial Results & Business Update

03:28

Volition signs global Supply Agreement for Nu.Q® Vet Cancer Test

03:57

What is NETosis?

01:34

What is Nu.Q® Discover?

06:12

Second Quarter 2022 Financial Results & Business Update

06:47

German Subtitles - Capital Markets Day May 2022

06:47

Capital Markets Day 2022 Highlights

08:10

First Quarter 2022 Results and Business Update

03:24

Highlights from WVC Annual Conference 2022

11:32

Full Year 2021 Financial Results and Business Update

05:46

Volition signs exclusive license and supply agreement with Heska Corporation.

04:40

Volition Business Update 2021

02:51

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Test in Asia

03:38

Highlights from London Vet Show 2021

14:51

Third Quarter 2021 Financial Results and Business Update for Volition – with German subtitles

14:51

Third Quarter 2021 Financial Results and Business Update for Volition

05:16

VCS 2021:Evaluation of Nu.Q Vet as a tool for treatment and disease monitoring in caner bearing dogs

07:53

VCS 2021:Enrichment tools to better understand types of circulating nucleosomes and genome patterns

03:37

Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference

16:44

Second Quarter 2021 Results and Business Update (with German subtitles)

12:27

Proactive Investor Interview with Cameron Reynolds, Volition's President and Chief Executive Officer

16:44

Second Quarter 2021 Results and Business Update - Volition

11:50

Business Update and Dr Tom Butera Introduction

12:03

Volition's First Quarter 2021 Financial Results and Business Update Interview

14:31

Fourth Quarter and Full Fiscal Year 2020 Results & Business Update for Volition.

03:04

A short film with Dr. Jake Micallef

10:23

An interview with Cameron Reynolds providing a Volition Update and introduction of New Team Members.

24:40

An interview with Volition's Chief Executive Officer, Cameron Reynolds for Edison's Open House

03:07

Nu.Q Data presented at the World Conference on Lung Cancer

02:47

Volition Opens its New Manufacturing Facility in Belgium

06:25

How to use the Nu.Q Vet Cancer Screening Test - with Dr Sue Ettinger.

02:16

Volition launches Nu.Q™ Vet Cancer Screening Test in the U.S.

09:12

Third Quarter 2020 Results Video (with German Subtitles)

06:50

Volition COVID-19 presentation at MEDICA 2020

11:02

Proactive Investors Interview with Cameron Reynolds Q3 Earnings 2020 and Business Update